19-45553912-C-G
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_025136.4(OPA3):c.143-1G>C variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.00000207 in 1,450,454 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_025136.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- optic atrophy 3Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), G2P
- 3-methylglutaconic aciduria type 3Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_025136.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| OPA3 | TSL:1 MANE Select | c.143-1G>C | splice_acceptor intron | N/A | ENSP00000263275.4 | Q9H6K4-1 | |||
| OPA3 | TSL:1 | c.143-24456G>C | intron | N/A | ENSP00000319817.3 | Q9H6K4-2 | |||
| OPA3 | TSL:2 | c.-17-1G>C | splice_acceptor intron | N/A | ENSP00000442839.1 | B4DK77 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000207 AC: 3AN: 1450454Hom.: 0 Cov.: 33 AF XY: 0.00000139 AC XY: 1AN XY: 719224 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at